WYNNEFIELD PARTNERS SMALL CAP VALUE LP I 13D and 13G filings for Lifecore Biomedical, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-07-05 2:17 pm Purchase |
2024-06-28 | 13D | Lifecore Biomedical, Inc. LFCR |
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 5,007,666 16.000% |
80,871 (+1.64%) |
Filing |
| 2024-07-02 4:54 pm Purchase |
2024-06-28 | 13D | Lifecore Biomedical, Inc. LFCR |
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 5,007,666 16.000% |
5,007,666 (New Position) |
Filing |
| 2023-03-16 4:15 pm Purchase |
2023-01-09 | 13D | Lifecore Biomedical, Inc. LFCR |
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 4,926,795 16.600% |
464,285 (+10.40%) |
Filing |
| 2022-12-02 4:15 pm Purchase |
2022-11-25 | 13D | Lifecore Biomedical, Inc. LFCR |
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 4,462,510 14.800% |
884,805 (+24.73%) |
Filing |
| 2022-01-20 4:16 pm Purchase |
2022-01-12 | 13D | Lifecore Biomedical, Inc. LFCR |
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 3,577,705 12.100% |
387,400 (+12.14%) |
Filing |
| 2021-04-20 4:15 pm Purchase |
2021-04-12 | 13D | Lifecore Biomedical, Inc. LFCR |
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 3,190,305 10.900% |
507,905 (+18.93%) |
Filing |